▼ SELL
10b5-1 Plan
$ Value
$891K
Shares
3,644
Price
$245
Filed
May 27
Insider
Name
Sandercock Brett
Title
Chief Financial Officer
CIK
0001346064
Roles
Officer
Transaction Details
Transaction Date
2025-05-22
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
86,283
Footnotes
The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025. | Includes 62.6994 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan.
Filing Info
Sandercock Brett's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | RMD | ▼ | $224K |
| 2026-01-02 | RMD | ▼ | $242K |
| 2025-12-01 | RMD | ▼ | $244K |
| 2025-11-20 | RMD | A | $0 |
| 2025-11-03 | RMD | M | $203K |
| 2025-11-03 | RMD | ▼ | $743K |
| 2025-11-03 | RMD | M | $0 |
| 2025-10-01 | RMD | M | $203K |
| 2025-10-01 | RMD | ▼ | $823K |
| 2025-10-01 | RMD | M | $0 |
Other Insiders at RMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FARRELL PETER C | — | $450K | 2026-04-01 |
|
Sandercock Brett
Chief Financial Officer
|
— | $224K | 2026-04-01 |
|
Farrell Michael J.
Chairman and CEO
|
— | $1.1M | 2026-04-07 |